These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inducible protective processes in animal systems: adaptive response to a low dose of methyl methanesulfonate in mouse bone marrow cells. Mahmood R; Vasudev V; Harish SK; Guruprasad KP Indian J Exp Biol; 1996 Jun; 34(6):502-7. PubMed ID: 8792636 [TBL] [Abstract][Full Text] [Related]
25. Induction of specific-locus mutations in male mice by ethyl methanesulfonate (EMS). Ehling UH; Neuhäuser-Klaus A Mutat Res; 1989 Oct; 227(2):91-5. PubMed ID: 2797047 [TBL] [Abstract][Full Text] [Related]
26. A mechanism-based cancer risk assessment for 1,4-dichlorobenzene. Butterworth BE; Aylward LL; Hays SM Regul Toxicol Pharmacol; 2007 Nov; 49(2):138-48. PubMed ID: 17688981 [TBL] [Abstract][Full Text] [Related]
27. Relationship between acute and chronic exposures in mutagenicity studies in mice. Srám RJ Mutat Res; 1976 Nov; 41(1 spel. no):25-42. PubMed ID: 64927 [TBL] [Abstract][Full Text] [Related]
28. Embryotoxicity induced by alkylating agents: 9. Low dose prenatal-toxic risk estimation of ethylmethanesulfonate based on no-observed-adverse-effect-level risk factor approach, dose-response relationships, and molecular dosimetry. Platzek T; Bochert G; Meister R Teratog Carcinog Mutagen; 1995; 15(2):81-92. PubMed ID: 8525471 [TBL] [Abstract][Full Text] [Related]
29. [Postnatal and transplacental carcinogenic effects of methyl methanesulphonate (MMS) and ethyl methanesulphonate (EMS) in hooded rats (author's transl)]. Schneider J; Warzok R; Schreiber D; Heiderstädt R Exp Pathol (Jena); 1978; 16(1-6):157-67. PubMed ID: 214322 [TBL] [Abstract][Full Text] [Related]
31. Model averaging using fractional polynomials to estimate a safe level of exposure. Faes C; Aerts M; Geys H; Molenberghs G Risk Anal; 2007 Feb; 27(1):111-23. PubMed ID: 17362404 [TBL] [Abstract][Full Text] [Related]
32. The induction of urothelial hyperplasia by methyl methanesulphonate and ethyl methanesulphonate. Tudor RJ; Severs NJ; Hicks RM Br J Cancer; 1983 Aug; 48(2):289-300. PubMed ID: 6882667 [TBL] [Abstract][Full Text] [Related]
33. Transgenerational effects from exposure to environmental toxic substances. Nomura T Mutat Res; 2008; 659(1-2):185-93. PubMed ID: 18406661 [TBL] [Abstract][Full Text] [Related]
34. Germ-cell mutagenesis and GSH depression in reproductive tissue of the F-344 rat induced by ethyl methanesulfonate. Teaf CM; Harbison RD; Bishop JB Mutat Res; 1985 Oct; 144(2):93-8. PubMed ID: 4047076 [TBL] [Abstract][Full Text] [Related]
35. Nonlinearity and thresholds in dose-response relationships for carcinogenicity due to sampling variation, logarithmic dose scaling, or small differences in individual susceptibility. Lutz WK; Gaylor DW; Conolly RB; Lutz RW Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):565-9. PubMed ID: 15982698 [TBL] [Abstract][Full Text] [Related]
36. [TK locus mutation assay: comparison of L5178Y and TK6 cell lines]. Shuai PQ; Zhang LS; Wang YJ Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):650-3. PubMed ID: 15460410 [TBL] [Abstract][Full Text] [Related]
37. Induction of specific-locus and dominant lethal mutations in male mice in the low dose range by methyl methanesulfonate (MMS). Ehling UH; Neuhäuser-Klaus A Mutat Res; 1990 May; 230(1):61-70. PubMed ID: 2342498 [TBL] [Abstract][Full Text] [Related]
38. DNA alkylation studies of combined treatment with methylnitrosourea and ethylmethanesulfonate in mice. Platzek T; Bochert G Teratog Carcinog Mutagen; 2000; 20(1):27-34. PubMed ID: 10607375 [TBL] [Abstract][Full Text] [Related]